Unusual 11 Mid-Day Movers 10/14: (CTRV) (FBMS) (MGT) Higher; (OPTT) (TAYD) (BIOC) Lower

October 14, 2016 12:48 PM EDT
Get Alerts CTRV Hot Sheet
Trade CTRV Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

ContraVir Pharmaceuticals, Inc. (Nasdaq: CTRV) 31.6% HIGHER; reported positive interim data for CMX157, the Company's highly potent prodrug of tenofovir, from its ongoing Phase 2a multiple ascending dose clinical study. The head-to-head study is the first evaluation of CMX157 in HBV patients, and directly compares CMX157 to tenofovir disoproxil fumarate (TDF, Gilead's Viread) in chronically infected hepatitis B (HBV) patients.

Ocean Power Technologies (Nasdaq: OPTT) 27.1% LOWER; On October 14, 2016, Ocean Power Technologies, Inc., entered into an Underwriting Agreement with Roth Capital Partners, LLC and Maxim Group LLC, on behalf of the several underwriters, for the public offering of 2,400,000 shares of the Company’s common stock, par value $.001 per share, and an additional 360,000 shares of Common Stock to cover any over-allotments, at a price to the public of $2.75 per share. For more color, click here.

Taylor Devices (Nasdaq: TAYD) 25.2% LOWER; reported Q1 EPS of $0.06, versus $0.30 reported last year. Revenue for the quarter came in at $5.76 million, versus $9.47 million reported last year.

Biocept, Inc. (Nasdaq: BIOC) 22.5% LOWER; announces the pricing of an underwritten public offering of 9,100,000 shares of its common stock and warrants to purchase up to an aggregate of 9,100,000 shares of its common stock at a combined offering price of $1.10. The warrants will have a per share exercise price of $1.10, are exercisable immediately and will expire five years from the date of issuance. The gross proceeds to Biocept from this offering are expected to be approximately $10,010,000, before deducting the underwriting discount and estimated offering expenses payable by Biocept.

Natural Health Trends Corp. (Nasdaq: NHTC) 22.4% LOWER; reported preliminary Q3 results. The Company estimates total revenue for the quarter ended September 30, 2016 to be $70.7 million, which represents a decrease of 12% compared to $80.8 million in the third quarter of 2015. The Company further estimates that its deferred revenue at September 30, 2016 was $4.2 million, compared to $8.8 million at June 30, 2016. At September 30, 2015, deferred revenue was $4.5 million, compared to $8.2 million at June 30, 2015.

First Bancshares (Nasdaq: FBMS) 22.2% HIGHER; reported Q3 EPS of $0.45, versus $0.39 reported last year.

Flex Pharma (Nasdaq: FLKS) Cantor Fitzgerald downgraded Flex Pharma (Nasdaq: FLKS) from Buy to Hold with a price target of $10.00 (from $22.00).

MGT Capital Investments, Inc. (NYSE: MGT) 17.1% HIGHER; announce the commercial release of its first network security product designed by whitehat hackers and John McAfee.

Ruby Tuesday (NYSE: RT) 11.7% HIGHER; insiders disclosed recent stock purchases. For more color, click here.

Enzo Biochem (NYSE: ENZ) 10.5% HIGHER; reported Q4 EPS of $0.77, versus $0.18 reported last year. Revenue for the quarter came in at $26.6 million, versus $25.7 million reported last year.

Skyline Corporation (NYSE: SKY) 8.6% HIGHER; reported Q1 EPS of $0.09, versus ($0.10) reported last year. Revenue for the quarter came in at $61.2 million, versus $48.74 million reported last year.

To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Special Reports

Related Entities

Cantor Fitzgerald, Roth Capital, Maxim Group, Unusual 11 Mid-Day Movers

Add Your Comment